Sanofi Appoints Belén Garijo as Next CEO; Paul Hudson to Step Down

Sanofi (SAN) announced that Paul Hudson will step down as CEO, effective February 28, 2026, following a strategic leadership review. The company has named Belén Garijo, currently president of global business development, as the interim CEO until the board's formal appointment. Garijo will assume the role of CEO upon completion of the board's formal election process, which is expected to be finalized by March 2026. The transition is designed to ensure continuity during a critical phase of the company's portfolio and global operations.